Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis

被引:93
作者
Kuempers, Philipp [1 ]
van Meurs, Matijs [2 ,3 ]
David, Sascha [1 ]
Molema, Grietje [3 ]
Bijzet, Johan [3 ]
Lukasz, Alexander [1 ]
Biertz, Frank [4 ]
Haller, Hermann [1 ]
Zijlstra, Jan G. [2 ]
机构
[1] Hannover Med Sch, Dept Hypertens & Nephrol, D-30625 Hannover, Germany
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, NL-9713 GZ Groningen, Netherlands
[3] Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-19713 GZ Groningen, Netherlands
[4] Hannover Med Sch, Dept Biometr, D-30625 Hannover, Germany
关键词
EXCESS CIRCULATING ANGIOPOIETIN-2; TIE-2 LIGAND ANGIOPOIETIN-2; ACTIVATED PROTEIN-KINASE; CRITICALLY-ILL PATIENTS; ORGAN DYSFUNCTION; ANIMAL-MODELS; SEPTIC SHOCK; INFLAMMATION; EXPRESSION; MORTALITY;
D O I
10.1186/cc7866
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction Endothelial activation leading to vascular barrier breakdown denotes a devastating event in sepsis. Angiopoietin (Ang)-2, a circulating antagonistic ligand of the endothelial specific Tie2 receptor, is rapidly released from Weibel-Palade and has been identified as a non-redundant gatekeeper of endothelial activation. We aimed to study: the time course of Ang-2 release during human experimental endotoxemia; the association of Ang-2 with soluble adhesion molecules and inflammatory cytokines; and the early time course of Ang-2 release during sepsis in critically ill patients. Methods In 22 healthy volunteers during a 24-hour period after a single intravenous injection of lipopolysaccharide (LPS; 4 ng/kg) the following measurement were taken by immuno luminometric assay (ILMA), ELISA, and bead-based multiplex technology: circulating Ang-1, Ang-2, soluble Tie2 receptor, the inflammatory molecules TNF-alpha, IL-6, IL-8 and C-reactive protein, and the soluble endothelial adhesion molecules intercellular adhesion molecule-1 (ICAM-1), E-selectin, and P-selectin. A single oral dose of placebo or the p38 mitogen activated protein (MAP) kinase inhibitor drug, RWJ-67657, was administered 30 minutes before the endotoxin infusion. In addition, the course of circulating Ang-2 was analyzed in 21 septic patients at intensive care unit (ICU) admission and after 24 and 72 hours, respectively. Results During endotoxemia, circulating Ang-2 levels were significantly elevated, reaching peak levels 4.5 hours after LPS infusion. Ang-2 exhibited a kinetic profile similar to early proinflammatory cytokines TNF-alpha, IL-6, and IL-8. Ang-2 levels peaked prior to soluble endothelial-specific adhesion molecules. Finally, Ang-2 correlated with TNF-alpha levels (r = 0.61, P = 0.003), soluble E-selectin levels (r = 0.64, P < 0.002), and the heart rate/mean arterial pressure index (r = 0.75, P < 0.0001). In septic patients, Ang-2 increased in non-survivors only, and was significantly higher compared with survivors at baseline, 24 hours, and 72 hours. Conclusions LPS is a triggering factor for Ang-2 release in men. Circulating Ang-2 appears in the systemic circulation during experimental human endotoxemia in a distinctive temporal sequence and correlates with TNF-alpha and E-selectin levels. In addition, not only higher baseline Ang-2 concentrations, but also a persistent increase in Ang-2 during the early course identifies septic patients with unfavorable outcome.
引用
收藏
页数:9
相关论文
共 36 条
[1]   The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome [J].
Aird, WC .
BLOOD, 2003, 101 (10) :3765-3777
[2]   Selective release of molecules from Weibel-Palade bodies during a lingering kiss [J].
Babich, Victor ;
Meli, Athinoula ;
Knipe, Laura ;
Dempster, John E. ;
Skehel, Paul ;
Hannah, Matthew J. ;
Carter, Tom .
BLOOD, 2008, 111 (11) :5282-5290
[3]  
DAVID S, 2009, J HYPERTENS IN PRESS
[4]   Animal models of sepsis: Why does preclinical efficacy fail to translate to the clinical setting? [J].
Dyson, Alex ;
Singer, Mervyn .
CRITICAL CARE MEDICINE, 2009, 37 (01) :S30-S37
[5]   The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Paladebodies [J].
Fiedler, U ;
Scharpfenecker, M ;
Koidl, S ;
Hegen, A ;
Grunow, V ;
Schmidt, JM ;
Kriz, W ;
Thurston, G ;
Augustin, HG .
BLOOD, 2004, 103 (11) :4150-4156
[6]   Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats [J].
Fiedler, U ;
Krissl, T ;
Koidl, S ;
Weiss, C ;
Koblizek, T ;
Deutsch, U ;
Martiny-Baron, G ;
Marmé, D ;
Augustin, HG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1721-1727
[7]   Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation [J].
Fiedler, U ;
Reiss, Y ;
Scharpfenecker, M ;
Grunow, V ;
Koidl, S ;
Thurston, G ;
Gale, NW ;
Witzenrath, M ;
Rosseau, S ;
Suttorp, N ;
Sobke, A ;
Herrmann, M ;
Preissner, KT ;
Vajkoczy, P ;
Augustin, HG .
NATURE MEDICINE, 2006, 12 (02) :235-239
[8]   Angiopoietins: a link between angiogenesis and inflammation [J].
Fiedler, Ulrike ;
Augustin, Helimut G. .
TRENDS IN IMMUNOLOGY, 2006, 27 (12) :552-558
[9]   Inhibition of p38 mitogen-activated protein kinase: Dose-dependent suppression of leukocyte and endothelial response after endotoxin challenge in humans [J].
Fijen, JW ;
Tulleken, JE ;
Kobold, ACM ;
de Boer, P ;
van der Werf, TS ;
Ligtenberg, JJM ;
Spanjersberg, R ;
Zijlstra, JG .
CRITICAL CARE MEDICINE, 2002, 30 (04) :841-845
[10]   Suppression of the clinical and cytokine response to endotoxin by RWJ-67657, a p38 mitogen-activated protein-kinase inhibitor, in healthy human volunteers [J].
Fijen, JW ;
Zijlstra, JG ;
De Boer, P ;
Spanjersberg, R ;
Tervaert, JWC ;
Van der Werf, TS ;
Ligtenberg, JJM ;
Tulleken, JE .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 124 (01) :16-20